Skip to main content
. Author manuscript; available in PMC: 2016 Sep 28.
Published in final edited form as: JACC Cardiovasc Imaging. 2016 Apr;9(4):364–372. doi: 10.1016/j.jcmg.2016.02.010

Table 2.

Predictors of MACE

Univariate Multivariate*
HR (95% CI) p-value HR (95% CI) p-value
Age 1.04 (1.03-1.05) <0.001 1.03 (1.02-1.04) <0.001
Female gender 0.97 (0.84-1.12) 0.68
Hypertension 1.51 (1.31-1.75) <0.001 1.24 (1.02-1.51) 0.035
Hyperlipidemia 0.93 (0.81-1.07) 0.32
Diabetes 1.92 (1.64-2.25) <0.001 1.42 (1.16-1.74) 0.001
Smoking 1.20 (1.03-1.41) 0.03 1.48 (1.21-1.82) <0.001
Family History 0.90 (0.77-1.06) 0.21
Typical Angina 1.52 (1.25-1.85) <0.001 1.30 (1.01-1.66) 0.038
Atypical Angina 0.98 (0.83-1.16) 0.82 0.99 (0.79-1.24) 0.904
Noncardiac Chest Pain 0.84 (0.67-1.05) 0.12 1.12 (0.85-1.66) 0.396
Dyspnea 1.50 (1.22-1.84) <0.001
Aspirin 1.63 (1.37-1.94) <0.001
Beta blocker 1.25 (1.04-1.50) 0.02
ACE/ARB 1.58 (1.32-1.88) <0.001 1.26 (1.04-1.52) 0.017
Statin 1.36 (1.14-1.62) <0.001
Non-obstructive disease 0.95 (0.81-1.10) 0.47 2.25 (1.66-3.05) <0.001
1-vessel obstructive disease 1.65 (1.40-1.93) <0.001 2.86 (2.08-3.94) <0.001
2-vessel obstructive disease 1.73 (1.41-2.11) <0.001 3.46 (2.44-4.91) <0.001
3-vessel obstructive disease 2.42 (1.99-2.95) <0.001 4.68 (3.31-6.61) <0.001
Early revascularization 2.41 (2.07-2.80) <0.001
*

Hazard ratios shown only for variables retained.